BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10597047)

  • 1. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
    Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
    Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation.
    Hoshino K; Asou N; Suzushima H; Osato M; Yamasaki H; Okubo T; Nishimura S; Kiyokawa T; Kawano F; Takatsuki K
    Int J Hematol; 1997 Aug; 66(2):213-8. PubMed ID: 9277052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.
    Rho JK; Kim JH; Yu J; Choe SY
    Biochem Biophys Res Commun; 2002 Sep; 297(1):91-5. PubMed ID: 12220513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
    Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
    Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TEL fusion genes in pediatric leukemias.
    Rubnitz JE; Pui CH; Downing JR
    Leukemia; 1999 Jan; 13(1):6-13. PubMed ID: 10049061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.
    Steffen B; Serve H; Berdel WE; Agrawal S; Linggi B; Büchner T; Hiebert SW; Müller-Tidow C
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8448-53. PubMed ID: 12819347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
    Fears S; Chakrabarti SR; Nucifora G; Rowley JD
    Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of TEL proteins in human leukemias.
    Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
    Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
    Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
    Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia.
    Mangolini M; de Boer J; Walf-Vorderwülbecke V; Pieters R; den Boer ML; Williams O
    Blood; 2013 Jul; 122(4):542-9. PubMed ID: 23741012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.
    Iqbal Z
    Asian Pac J Cancer Prev; 2014; 15(8):3541-6. PubMed ID: 24870754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.